UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:February 24,
Organovo (NASDAQ:ONVO)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Organovo Charts.
Organovo (NASDAQ:ONVO)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Organovo Charts.

Organovo Holdings, Inc. News

Organovo Data Presented at Digestive Disease Week (DDW2024) Demonstrating Potential for FXR314 as Combination Therapy with Tofacitinib for Inflammatory Bowel Disease
Tuesday 21 May 2024 (2 days ago) • GlobeNewswire Inc.
Form 424B4 - Prospectus [Rule 424(b)(4)]
Wednesday 15 May 2024 (1 week ago) • Edgar (US Regulatory)
Organovo to Present Data on FXR314 at Digestive Diseases Week (DDW2024)
Wednesday 15 May 2024 (1 week ago) • GlobeNewswire Inc.
Form 8-K - Current report
Tuesday 14 May 2024 (1 week ago) • Edgar (US Regulatory)
Form 424B4 - Prospectus [Rule 424(b)(4)]
Saturday 11 May 2024 (2 weeks ago) • Edgar (US Regulatory)
Organovo Holdings, Inc. Announces Pricing of $5.25 Million Public Offering
Thursday 9 May 2024 (2 weeks ago) • GlobeNewswire Inc.
Organovo Announces Positive Phase 2 Results for FXR314 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Showing Both Reduction in Liver Fat Content and Strong Safety and Tolerability Compared to Placebo
Monday 15 April 2024 (1 month ago) • GlobeNewswire Inc.
Form EFFECT - Notice of Effectiveness
Friday 9 February 2024 (3 months ago) • Edgar (US Regulatory)
Form 424B5 - Prospectus [Rule 424(b)(5)]
Friday 9 February 2024 (3 months ago) • Edgar (US Regulatory)
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Friday 9 February 2024 (3 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Thursday 8 February 2024 (3 months ago) • Edgar (US Regulatory)
Form S-3 - Registration statement under Securities Act of 1933
Saturday 27 January 2024 (4 months ago) • Edgar (US Regulatory)

More Organovo Holdings, Inc. News Articles